Compression therapy is a medical procedure in which external pressure is applied to the skin and underlying structure (organ) to promote normal flow of venous blood in the body. Recognized as a gold standard for treating lymphedema, chronic venous insufficiency, and deep vein thrombosis, compression therapy is safe, easy-to-use and provides effective treatment in a short time span. The therapy aims to increase venous and lymphatic fluid in the limb through the utilization of an external force (exerted by compression products). This report studies the current scenario as well as future market potential for compression therapy across the globe. The research comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. The report provides in-depth analysis of the compression therapy market. The stakeholders for this report include companies involved in the manufacturing of compression pumps, bandages, tapes and stocking. The executive summary section further summarizes the market size, trends and competition in different regions.

Transparency Market Research forecasts the global compression therapy market to reach US$4.25 bn by 2024 from a valuation of US$2,693.4 mn in 2015. If these figures hold true, the market will exhibit a CAGR of 5.3% between 2016 and 2024.

Prevalence of Obesity Creates Ample Opportunities for Expansion of Compression Therapy Market in Developed Economies

The American Academy of Orthopedic Surgeons (AAOS) has stated that around 129,000 knee arthroplasty surgeries were conducted in the U.S. in 1990. The number had reached over 600,000 surgeries in 2010. Furthermore, the AAOS projects the number of arthroplasty surgeries to be conducted in the U.S. by 2030 to surpass 3 million. Considering the incredible rise in number of cases reported in the U.S. alone, the incidence of orthopedic conditions globally is projected to increase at a rapid pace. This creates ample opportunities for the expansion of the compression therapy market.

As obesity increases the risk of vascular diseases due to the pressure exerted by the bodyweight on underlying organs, its rising prevalence is often linked with the increasing demand for compression therapy. As per the World Health Organization (WHO), the prevalence of obesity has nearly doubled since 1980. With experts projecting the number to surge during the report’s forecast period, opportunities for the global compression therapy market are likely to bolster.

Lack of proper reimbursement policies will, however, limit the market’s success to an extent, finds TMR. Nevertheless, the rising investments in emerging economies and widespread unmet medical needs in these countries will support the market’s growth in the near future.

North America Emerges Dominant with Most Attractive Opportunities

Regionally, North America has been exhibiting the most lucrative prospects for leading enterprises in the market. The region held around 47.2% of the market in 2015, followed by Europe, which accounted for a share of 32.2% in the market in the same year. The prevalence of vascular diseases in both these regions is relatively higher. In North America, TMR finds the alarming rate of obesity as a prime driver of the compression therapy market. Among other regions exhibiting prospects for the compression therapy market, Asia Pacific is expected to report the highest CAGR.

Demand for static compression therapy is forecast to rise at a rapid pace. The segment in 2015 held the largest share in the market and is expected to sustain its dominant position through the forecast period. The low cost and easy availability of static compression products have consequently boosted their sales. These products are also supported by clinical evidence, due to which doctors around the world seem to prefer static garments more. Besides this, the aesthetic appearance and comfortable material of static compression hosiery have made them a preferred choice among patients.